新開源(300109.SZ):董事王堅強、張軍政參投健馨生物
格隆匯5月13日丨新開源(300109.SZ)公佈,公司接到公司董事王堅強、張軍政的通知,王堅強及張軍政擬受讓健馨生物原股東華茂偉業綠色科技股份有限公司(“華茂偉業”)部分股權。公司董事王堅強、張軍政分別擬以自有資金190萬元、40萬元人民幣受讓原股東華茂偉業部分股權,此次股權轉讓完成後,王堅強持有健馨生物0.633%的股權,張軍政持有健馨生物0.133%的股權。
健馨生物原股東華茂偉業擬將其持有的2%的股權(價值為145.4545萬元,華茂偉業已出資50萬元,尚欠繳95.4545萬元)分別轉讓給汪宇、王堅強、郭興臣、安洪洲、吳俊俊、楊曉傑、張軍政、方鄂和張明威等九人(以下簡稱“受讓方”),健馨生物原股東放棄優先受讓權。以上受讓方合計以600萬元受讓華茂偉業持有健馨生物2%股權,其中50萬元為股權轉讓款(其中24萬元已計入註冊資本,26萬元已計入資本公積金),550萬元計入健馨生物資本公積金。
此次投資是基於王堅強及張軍政個人對健馨生物未來市場發展前景作出的判斷,不會對公司財務及經營狀況產生重大不利影響,不存在損害公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.